RNA mutations of prox1 detected in human esophageal cancer cells by the shifted termination assay

Biochemical and Biophysical Research Communications

Volumn 359, Issue 2, 2007, Pages 258-262

  Yoshimoto, Takanobu ^a   Takahashi, Meiko ^a   Nagayama, Satoshi ^b   Watanabe, Go ^b   Shimada, Yutaka ^b   Sakasi, Yoshiharu ^b   Kubo, Hajime ^a  

^a Kyoto Umversity Graduate School of Medicine   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Mutector; Prox1; RNA mutation; Shifted termination assay

Indexed keywords

COMPLEMENTARY DNA; RNA;

ARTICLE; CANCER CELL; CELL LINE; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE AMPLIFICATION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; GENOMICS; HUMAN; HUMAN CELL; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CARCINOMA; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, COMPLEMENTARY; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MODELS, GENETIC; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

EID: 34249944405     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.071     Document Type: Article

References (11)

1. Shimoda M., Takahashi M., Yoshimoto T., Kono T., Ikai I., and Kubo H. A homeobox protein, prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma. Clin. Cancer Res. 12 20 Pt. 1 (2006) 6005-6011
2. Takahashi M., Yoshimoto T., Shimoda M., Kono T., Koizumi M., Yazumi S., Shimada Y., Doi Y., Chiba T., and Kubo H. Loss of function of the candidate tumor suppressor prox1 by RNA mutation in human cancer cells. Neoplasia 8 (2006) 1003-1010
3. Tam W., Gomez M., Chadburn A., Lee J.W., Chan W.C., and Knowles D.M. Mutational analysis of PRDM1 indicates a tumor suppressor role in diffuse large B-cell lymphomas. Blood 107 (2006) 1090-1100
4. Klimek-Tomczak K., Mikula M., Dzwonek A., Paziewska A., Karczmarski J., Hennig E., Bujnicki J.M., Bragoszewski P., Denisenko O., Bomsztyk K., et al. Editing of hnRNP K protein mRNA in colorectal adenocarcinoma and surrounding mucosa. Br. J. Cancer 94 (2006) 586-592
5. Shackelford W., Deng S., Murayama K., and Wang J. A new technology for mutation detection. Ann. N. Y. Acad. Sci. 1022 (2004) 257-262
6. Cohen Y., Rosenbaum E., Begum S., Goldenberg D., Esche C., Lavie O., Sidransky D., and Westra W.H. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin. Cancer Res. 10 10 (2004) 3444-3447
7. Goldenberg D., Rosenbaum E., Argani P., Wistuba I.I., Sidransky D., Thuluvath P.J., Hidalgo M., Califano J., and Maitra A. The V599E BRAF mutation is uncommon in biliary tract cancers. Mod. Pathol. 17 11 (2004) 1386-1391
8. Goldenberg-Cohen N., Cohen Y., Rosenbaum E., Herscovici Z., Chowers I., Weinberger D., Pe'er J., and Sidransky D. T1799A BRAF mutations in conjunctival melanocytic lesions. Invest. Ophthalmol. Vis. Sci. 46 9 (2005) 3027-3030
9. Morrison S., and Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441 (2006) 1068-1074
10. Caussinus E., and Gonzalez C. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat. Genet. 37 (2005) 1125-1129
11. Regala R.P., Weems C., Jamieson L., Khoor A., Edell E.S., Lohse C.M., and Fields A.P. Atypical protein kinase C iota is an oncogene in human non - small cell lung cancer. Cancer Res. 65 (2005) 8905-8911